Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2022 by Sydney Thomas, Symphonic Capital is a venture capital firm based in Oakland, California. With a focus on early-stage startups, the firm has successfully raised a debut fund of $13.5 million, which closed in April 2025. Symphonic Capital specializes in investing in companies with a minimum viable product valued at $10 million or less, emphasizing a collaborative approach to building sustainable businesses. The firm is dedicated to addressing significant issues that impact marginalized communities, particularly in the sectors of healthcare and financial technology. With a strong backing from institutional limited partners, including Bank of America and the Mary Reynolds Babcock Foundation, Symphonic Capital has established a reputation for its commitment to health and wealth equity. The firm currently manages a portfolio of 17 companies, reflecting its strategic focus on empowering founders and supporting them throughout their growth journey.
Symphonic Capital invests primarily in early-stage companies within the healthcare and fintech sectors. The firm seeks to address critical issues that affect a broad audience, prioritizing long-term success and meaningful impact over high valuations or rapid returns. Their investment strategy is centered around health and wealth equity, particularly for overlooked and marginalized communities. Symphonic Capital typically invests between $100,000 and $250,000 in startups that are at the pre-seed and seed stages. The firm looks for companies that have a minimum viable product and are focused on solving core problems affecting the majority of people. By concentrating on health technology and financial technology, Symphonic Capital aims to close access gaps and provide essential services to underserved populations. The firm values operational guidance and strategic support, ensuring that founders are well-equipped to navigate the challenges of early-stage growth.
Symphonic Capital's portfolio includes a diverse range of innovative companies that are making significant strides in their respective fields. Notable investments include **Aura Finance**, which promotes a healthier and wealthier workforce, and **Bump**, a financial tool designed specifically for creatives. The firm also backs **Canopie**, a behavioral health platform focused on maternal mental health, and **Croux**, an AI-powered staffing platform connecting businesses with gig workers in hospitality. Other key portfolio companies include **Flourish Care**, which offers wellness programs for pregnant women, and **Honeycomb Credit**, enabling small businesses to secure loans from their communities. Additionally, **Remynt** focuses on customer-first debt and credit recovery, while **Rocket Doctor** provides Medicaid-focused digital health services. With a total of 17 companies in its portfolio, Symphonic Capital is committed to fostering growth and innovation in sectors that address health and wealth equity.
Sydney Thomas - Founder & General Partner. Sydney leads the firm with a focus on empowering early-stage startups, particularly in health and fintech sectors.
To pitch Symphonic Capital, visit their website at symphoniccapital.com or email your pitch to hi@symphonic.vc. The firm welcomes pitches that clearly articulate the problem being addressed and the potential impact of the solution.
Symphonic Capital recently closed its debut fund of $13.5 million in April 2025, marking a significant milestone for the firm. The fund has garnered attention from various media outlets, including Fortune and AfroTech, highlighting its commitment to investing in health and wealth equity for underserved communities.
Symphonic Capital primarily invests in pre-seed and seed stages, focusing on early-stage startups that have a minimum viable product valued at $10 million or less.
Founders can pitch Symphonic Capital by visiting their website at symphoniccapital.com or by emailing their pitch to hi@symphonic.vc. The firm prefers pitches that clearly outline the problem being solved and the impact of the solution.
Symphonic Capital focuses on healthcare and fintech sectors, particularly investing in companies that address health and wealth equity for marginalized communities.
The typical check size for Symphonic Capital ranges from $100,000 to $250,000, aimed at supporting early-stage startups in their growth journey.
Symphonic Capital primarily invests in startups based in the United States, focusing on companies that are addressing significant issues within their communities.
Symphonic Capital provides operational guidance and strategic support to its portfolio companies, emphasizing a collaborative approach to building sustainable businesses.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.